Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to assess the effect of Pirtobrutinib (LOXO-305) on the heart rate-corrected QT (QTc) interval and to conduct blood tests to measure how much pirtobrutinib (LOXO-305)...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eli Lilly and Company
Collaborators
NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched
NCT07545590 · Healthy
NCT07258836 · Neoplasms, Healthy
NCT00090662 · Healthy Volunteer
NCT07059858 · Intellectual Disability, Healthy Subjects
Covance Clinical Research Unit 1341 Mockingbird Lane
Dallas, Texas
Covance Clinical Research Unit 3402 Kinsman Blvd
Madison, Wisconsin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions